About Scanroof Life Sciences Private Limited
Data last updated:
Scanroof Life Sciences Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 20 October 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U74999KA2016PTC097264.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Meddworld Life Sciences Private Limited. It is led by directors Naveen Ramegowda Bikkalahalli and Munawar Neena.
Its last annual general meeting (AGM) was held on 28 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at No 3/1 Ground Floor 1st Cross Gangappa Block Ganganagar, Bangalore, Karnataka, India – 560032.
As per the financials filed for FY 2023, the company reported a revenue of ₹83.19 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹39.35 Lakh (net margin 47.3%) and EBITDA of ₹48.1 Lakh (EBITDA margin 57.8%). Revenue has grown at a compounded annual rate (CAGR) of 56% over three years and 25% over five years.
As per MCA filings, the company has open charges of ₹77.39 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website scanroofveinclinic.com.
Company details
Contact details
Scanroof Life Sciences Private Limited's registered office is in Bangalore, Karnataka. Its website is scanroofveinclinic.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressNo 3/1 Ground Floor 1st Cross Gangappa Block Ganganagar, Bangalore, Karnataka, India – 560032
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
To see the full contact details of Scanroof Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Scanroof Life Sciences is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Scanroof Life Sciences Private Limited, buy the company report.
Financials of Scanroof Life Sciences Private Limited
FY 2023 filings availableScanroof Life Sciences Private Limited reported revenue of ₹83.19 Lakh (up 175% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 25% over five years, including 175% growth in the latest year. EBITDA rose 81% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹83.19 Lakh | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹48.1 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹39.35 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 57.8% | ||||
| Net Profit Margin | 47.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Scanroof Life Sciences Private Limited, buy the company report.
Board of directors of Scanroof Life Sciences Private Limited
Scanroof Life Sciences has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Naveen Ramegowda Bikkalahalli Also directs: Medhill Diagnostics LLP | Director | 20 Oct 2016 | 10 Years 0 Months | Current |
| Munawar Neena | Director | 03 Mar 2023 | 3 Years 8 Months | Current |
Auditor
Scanroof Life Sciences Private Limited is audited by Gokhale & Gore for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Gokhale & Gore | FY 2023 | 018065S |
Shareholding
The shareholding of Scanroof Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Scanroof Life Sciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 Mar 2017 | 100085030 | Others | ₹25 Lakh | Open | |
| 20 Jan 2017 | 100084083 | Others | ₹20.3 Lakh | Open | |
| 20 Jan 2017 | 100084090 | Others | ₹12.21 Lakh | Open | |
| 20 Jan 2017 | 100084087 | Others | ₹19.89 Lakh | Open |
Total charge records: 4 View all charges
Legal cases
No court or tribunal cases involving Scanroof Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Scanroof Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Scanroof Life Sciences Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Scanroof Life Sciences Private Limited has 5 board changes on record since 2016: 2 appointments and 3 cessations. The latest: Munawar Neena was appointed as Director on 03 Mar 2023.
Frequently asked questions
Scanroof Life Sciences is an active private limited company based in Bangalore, Karnataka, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 20 October 2016 (10+ years old) and is registered under CIN U74999KA2016PTC097264.
Scanroof Life Sciences has 2 current directors:
- Naveen Ramegowda Bikkalahalli - Director
- Munawar Neena - Director
The latest financial statements of Scanroof Life Sciences on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 28 September 2023. Year-wise statements from FY 2017 are in the company report.
The CIN (Corporate Identification Number) of Scanroof Life Sciences is U74999KA2016PTC097264. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Scanroof Life Sciences was incorporated on 20 October 2016, making it 10+ years old. It is registered with the Registrar of Companies, Bangalore.
Munawar Neena was appointed as Director on 03 Mar 2023. Radhamma Subramani ceased to be Director on 04 Feb 2021. Sudhakar Sampangi ceased to be Additional Director on 10 Jul 2017. Scanroof Life Sciences has 5 board changes on record in total.
Scanroof Life Sciences can be reached through the website scanroofveinclinic.com. Its registered office is in Bangalore, Karnataka, India.
The registered office of Scanroof Life Sciences is at No 31 Ground Floor 1st Cross Gangappa Block Ganganagar, Bangalore, Karnataka, India – 560032.
Scanroof Life Sciences operates in the healthcare industry, in the diagnostic centers and pathology labs segment.
Scanroof Life Sciences has open charges of ₹77.39 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
